We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Electronic Health Records Speed Chlamydia Treatment

By HospiMedica International staff writers
Posted on 14 Jun 2010
Print article
Electronic health records (EHRs) can significantly shorten treatment times for patients diagnosed with the sexually transmitted infection (STI) Chlamydia, according to a new study.

Researchers at Central Middlesex Hospital (London, United Kingdom) examined the medical records of patients treated at a sexual health clinic, either before or after it converted to EHRs. For each of 52 consecutive qualifying patients seen from January to March 2007 (paper case records) and 2009 (EHRs), time intervals were measured between first attendance, first positive result received, first attempted patient contact, and attendance for treatment.

The researchers found that before the clinic adopted EHRs, it took an average of 11.5 days for a patient to receive treatment after a Chlamydia diagnosis, compared with just 3.5 days under the EHR system; and even though results took 2 days longer to arrive in 2009 than in 2007, the time between first attendance and treatment decreased by 9.5 days. In 2007, 38% of patients were treated within 2 weeks of a positive result, compared with 94% in 2009. EHRs were also associated with a greater proportion of patients successfully recalled by telephone, resulting in earlier treatment. The study was published online on May 27, 2010, in the journal Sexually Transmitted Infections.

"Compared with paper notes, EHR decreased the time to recall, by eliminating three time-delaying patient recall processes. The 'time to treat' interval was dramatically reduced after the introduction of EHR,” concluded lead author Gary Brook, M.D., and colleagues. "We suggest that with the increasing use of noninvasive Chlamydia screening methods such as urine sampling, and more effective patient recall, new national standards should be set for the time taken to recall and treat infected patients.”

Chlamydia infection is a common STI in humans caused by the bacterium Chlamydia trachomatis, which is found only in humans. Chlamydia is a major infectious cause of human genital and eye disease, and is one of the most common sexually transmitted infections worldwide; it is estimated that about 1 million individuals in the United States alone are infected with Chlamydia.

Related Links:

Central Middlesex Hospital


Gold Member
12-Channel ECG
CM1200B
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Oxygen Concentrator
Nuvo 10
New
Infusion Stand Rotatable Clamp
10-400 Infusion Stand Rotatable Clamp

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.